Request a Presentation Slot

The aim of the 2009 BIO Investor Forum is to bring together a select group of late-stage private and early-stage public biotech companies and top public and private equity investors to foster the development of important new medicines that will expand the industry’s pipeline. Companies interested in presenting must focus on biotechnology therapeutics. With this mission, companies exclusively developing medical devices, platform technologies, or diagnostics will not be considered. Companies that meet the stated criteria should FULLY complete the application form below.

All of the information provided below will be used for selection purposes only and will not be printed in conference handbooks or as profiles for the partnering system.

Click here for PDF version of the form below.

Company Information
Name of Company:
Address1:
Address2:
City:
State:
Postal Code:
Country:	United States Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua And Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia And Herzegowina Botswana Bouvet Island Brazil British Indian Ocean Terr Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo-Democratic Republic Cook Islands Costa Rica Cote DIvoire Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia European Community Falkland Islands Faroe Islands Fiji Finland France France - Metropolitan French Guiana French Polynesia French Southern Terr Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard & Mcdonald Islands Holy See (Vatican City ) Honduras Hong Kong Hungary Iceland India Indonesia INT Iran(Islamic Republic Of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea - People's Republic (North Korea) Korea - South Korea Kuwait Kyrgyzstan Lao People Demo Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia (Yugoslav Rep) Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia-Federated Stat Moldova - Republic Of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory, Occupied Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts And Nevis Saint Lucia Samoa San Marino Sao Tome And Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia(Slovak Republic) Slovenia Solomon Islands Somalia South Africa South Georgia Spain Sri Lanka St Vincent And Grenadines St. Helena St. Pierre And Miquelon Sudan Suriname Svalbard & Jan Mayen Isl Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania-United Republic Thailand Togo Tokelau Tonga Trinidad And Tobago Tunisia Turkey Turkmenistan Turks And Caicos Islands Tuvalu U S Minor Island Uganda Ukraine United Arab Emirates United Kingdom Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Virgin Islands (British) Wallis And Futuna Islands Western Sahara Yemen Yugoslavia Zambia Zimbabwe
Web Address:
Pipeline Web Address:
Primary Contact Name:
Primary Contact Title:
Primary Contact Email:
Direct Phone:
Ownership:	Private Public Other
Presentation Objective: (2,000 Characters or less)
Company Background:
Year of Incorporation:
Therapeutic Area(s) of Focus:
Company Description/Mission Statement: (2,000 characters or less)
Technology and Current Research: (2,000 characters or less):
Partnership Strategy and/or Current Alliances: (2,000 characters or less):
Recent Milestones: (250 characters or less):
Anticipated Milestones: (250 characters or less):
Company Management
Chief Executive Officer and Top Company Official:
Name:
Title:
Other Senior Officers:
Name:
Title:
Name:
Title:
Name:
Title:
Name:
Title:
Name:
Title:
Scientific Advisory Board:
Name:
Title:
Name:
Title:
Name:
Title:
Name:
Title:
Name:
Title:
Financing History
For Private Companies
Most Recent Round of Funding Completed:	Seed Round A Round B Round C Round D Round Other Round
Total Amount Raised to Date, in all rounds:
Previous and Current Investors: (List of up to 10)
For Public Companies
Market Cap:
Market Cap Date:
Exchange:
Ticker:
Additional Information:
(2,000 characters or less)